🇺🇸 Antihypertensive treatment in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Rhabdomyolysis — 2 reports (18.18%)
  2. Abnormal Behaviour — 1 report (9.09%)
  3. Akinesia — 1 report (9.09%)
  4. Amyotrophy — 1 report (9.09%)
  5. Anaemia — 1 report (9.09%)
  6. Asthenia — 1 report (9.09%)
  7. Ataxia — 1 report (9.09%)
  8. Blood Creatinine Increased — 1 report (9.09%)
  9. Blood Urea Increased — 1 report (9.09%)
  10. Bone Lesion — 1 report (9.09%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Antihypertensive treatment approved in United States?

Antihypertensive treatment does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Antihypertensive treatment in United States?

Asan Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.